A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in atrial fibrillation
, , , , e
23 ago 2022
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 23 ago 2022
Pagine: 91 - 101
Ricevuto: 14 apr 2022
Accettato: 04 giu 2022
DOI: https://doi.org/10.2478/acm-2022-0011
Parole chiave
© 2022 Raghu K. et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Raghu, K
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India
Ramakrishnan, TV
Emergency Department, Sri Ramachandra Medical College and Research InstituteChennai, India
Sreedevi, G
Emergency Department, Sri Ramachandra Medical College and Research InstituteChennai, India
Shreevani, P
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India
Gopala Krishna, S
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India
Ravishankar, B
Department of Emergency Medicine, Narayana Medical College and HospitalNellore, India